A business in context

IONS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-15 · 0000874015-26-000267

  2. 4 · Ownership change

    Report date 2026-10-15 · 0000874015-26-000266

  3. 8-K · Current report

    Report date 2026-09-23 · 0001140361-26-037371 · Items 7.01,8.01,9.01

  4. 8-K · Current report

    Report date 2026-09-04 · 0001140361-26-035802 · Items 7.01,8.01,9.01

  5. 8-K · Current report

    Report date 2026-09-03 · 0001140361-26-035657 · Items 7.01,8.01,9.01

  6. 4 · Ownership change

    Report date 2026-08-31 · 0000874015-26-000262

  7. 4 · Ownership change

    Report date 2026-08-31 · 0000874015-26-000261

  8. 4 · Ownership change

    Report date 2026-08-31 · 0000874015-26-000260

  9. 4 · Ownership change

    Report date 2026-08-31 · 0000874015-26-000259

  10. 4 · Ownership change

    Report date 2026-07-30 · 0000874015-26-000254

  11. 8-K · Current report

    Report date 2026-07-29 · 0001140361-26-029960 · Items 2.02,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000874015-26-000251

  13. 4 · Ownership change

    Report date 2026-07-15 · 0000874015-26-000247

  14. 8-K · Current report

    Report date 2026-07-09 · 0001140361-26-028154 · Items 7.01,9.01

  15. 8-K · Current report

    Report date 2026-07-09 · 0001140361-26-028092 · Items 7.01,8.01,9.01

  16. 8-K · Current report

    Report date 2026-06-24 · 0001140361-26-026232 · Items 7.01,8.01,9.01

  17. 8-K · Current report

    Report date 2026-06-12 · 0001140361-26-025050 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-06-04 · 0001140361-26-024407 · Items 5.02,5.07,7.01,9.01

  19. 8-K · Current report

    Report date 2026-05-28 · 0001140361-26-023093 · Items 7.01,8.01,9.01

  20. 8-K · Current report

    Report date 2026-04-29 · 0001140361-26-017637 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000874015-26-000177

  22. DEF 14A · Proxy statement

    Report date 2026-06-04 · 0001140361-26-016388

  23. 8-K · Current report

    Report date 2026-04-21 · 0001140361-26-015801 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2026-03-03 · 0001140361-26-008340 · Items 5.02,7.01,9.01

  25. 10-K · Annual report

    Report date 2025-12-31 · 0000874015-26-000115

  26. 8-K · Current report

    Report date 2026-02-25 · 0001140361-26-006718 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2026-01-12 · 0001140361-26-000893 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2026-01-07 · 0001140361-26-000435 · Items 7.01,8.01,9.01

  29. 8-K · Current report

    Report date 2025-11-11 · 0001193125-25-284609 · Items 1.01,2.03,3.02,8.01,9.01

  30. 8-K · Current report

    Report date 2025-11-08 · 0001140361-25-041225 · Items 7.01,8.01,9.01

  31. 8-K/A · Current report

    Report date 2025-10-28 · 0001140361-25-040220 · Items 1.01,9.01

  32. 8-K · Current report

    Report date 2025-10-29 · 0001140361-25-039650 · Items 2.02,9.01

  33. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000874015-25-000266

  34. 8-K · Current report

    Report date 2025-09-22 · 0001140361-25-035634 · Items 7.01,8.01,9.01

  35. 8-K · Current report

    Report date 2025-09-02 · 0001140361-25-033541 · Items 7.01,8.01,9.01

  36. 8-K · Current report

    Report date 2025-08-21 · 0001140361-25-032176 · Items 7.01,8.01,9.01

  37. 8-K · Current report

    Report date 2025-07-30 · 0001140361-25-027949 · Items 2.02,9.01

  38. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000874015-25-000167

  39. 8-K · Current report

    Report date 2025-06-12 · 0001140361-25-022267 · Items 5.02,9.01

  40. 8-K · Current report

    Report date 2025-06-05 · 0001140361-25-022001 · Items 5.07,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 6 transaction rows6SGrant / award: 16 transaction rows16AExercise / conversion: 8 transaction rows8MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

38 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-31
2026-09-02
BENNETT C FRANKJ · Other (see filing)
Acquired
Common Stock110.051.31
2026-08-31
2026-09-02
O'NEIL PATRICK R.J · Other (see filing)
Acquired
Common Stock63.051.31
2026-08-31
2026-09-02
Monia Brett PJ · Other (see filing)
Acquired
Common Stock98.051.31
2026-08-31
2026-09-02
Birchler BrianJ · Other (see filing)
Acquired
Common Stock58.051.31
2026-07-31
2026-07-31
Hayden Michael RP · Purchase
Acquired
Common Stock5000.051.6
2026-07-30
2026-07-31
Hayden Michael RP · Purchase
Acquired
Common Stock15000.053.38
2026-07-15
2026-07-17
Reikes Peter NA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
3399.00.0
2026-07-15
2026-07-17
HANTSON LUDWIGA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
3399.00.0
2026-07-15
2026-07-17
HERMAN JOAN EM · Exercise / conversion
Acquired
Common Stock5220.00.0
2026-07-15
2026-07-17
HERMAN JOAN EM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
5220.00.0
2026-07-15
2026-07-17
BERTHELSEN SPENCER RM · Exercise / conversion
Acquired
Common Stock5220.00.0
2026-07-15
2026-07-17
BERTHELSEN SPENCER RM · Exercise / conversion
Disposed
Restricted Stock Unit
Derivative security
5220.00.0
2026-07-07
2026-07-09
BENNETT C FRANK
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock15000.085.46
2026-07-07
2026-07-09
BENNETT C FRANK
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5536.083.58
2026-07-07
2026-07-09
BENNETT C FRANK
10b5-1 checkbox reported
J · Other (see filing)
Acquired
Common Stock15000.00.0
2026-07-07
2026-07-09
BENNETT C FRANK
10b5-1 checkbox reported
J · Other (see filing)
Disposed
Restricted Stock Unit
Derivative security
15000.00.0
2026-07-07
2026-07-09
Diaz Allene M.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10111.085.42
2026-07-07
2026-07-09
Diaz Allene M.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10111.047.11
2026-07-07
2026-07-09
Diaz Allene M.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
10111.00.0
2026-07-07
2026-07-09
Kordasiewicz Holly B.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock362.084.3
2026-07-01
2026-07-06
YANG MICHAEL J.A · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
YANG MICHAEL J.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
LOSCALZO JOSEPHA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
LOSCALZO JOSEPHA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
HERMAN JOAN EA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
HERMAN JOAN EA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock11518.039.94
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock99.079.45
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock11419.079.04
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
A · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
KLEIN JOSEPH III
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Non-Qualified Stock Option (right to buy)
Derivative security
11518.00.0
2026-07-01
2026-07-06
Hayden Michael RA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
Hayden Michael RA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
Diaz Allene M.A · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
Diaz Allene M.A · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0
2026-07-01
2026-07-06
BERTHELSEN SPENCER RA · Grant / award
Acquired
Non-Qualified Stock Option (right to buy)
Derivative security
5369.00.0
2026-07-01
2026-07-06
BERTHELSEN SPENCER RA · Grant / award
Acquired
Restricted Stock Unit
Derivative security
2301.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000874015IONIS PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • ISIS PHARMACEUTICALS INC · former SEC name · 1996-06-12 to 2015-12-18

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$705.14M$757.38M
2023-12-31$787.65M$870.93M
2022-12-31$587.37M$676.14M
2021-12-31$810.46M$1.01B
2020-12-31$729.26M$949.40M
2019-12-31$1.12B$1.48B
2018-12-31$599.67M$804.62M
2017-12-31$514.18M$706.77M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗